Device
Nervio-X
Nervio-X is a medical device with 4 clinical trials. Currently 2 active trials ongoing. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 1 completed trials
Completion Rate
100%(1/1)
Active Trials
2(50%)
Results Posted
0%(0 trials)
Phase Distribution
Ph not_applicable
4
100%
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution4 total trials
N/ANon-phased studies
4(100.0%)
Highest Phase Reached
UnknownTrial Status & Enrollment
Completion Rate
100.0%
1 of 1 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
2
trials recruiting
Total Trials
4
all time
Status Distribution
Active(3)
Completed(1)
Detailed Status
Recruiting2
Completed1
Enrolling by invitation1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
2
Success Rate
100.0%
Most Advanced
N/A
Trials by Phase
N/A4 (100.0%)
Trials by Status
completed125%
enrolling_by_invitation125%
recruiting250%
Recent Activity
2 active trials
Showing 4 of 4
enrolling_by_invitationnot_applicable
6 Weeks Right-Amygdala TIS for Depression
NCT07059143
completednot_applicable
Amygdala TIS for Depression
NCT06477276
recruitingnot_applicable
Amygdala MRI-TIS for Depression
NCT06461260
recruitingnot_applicable
Amygdala and dLPFC MRI-TIS for Depression in Adolescents
NCT06452849
Clinical Trials (4)
Showing 4 of 4 trials
NCT07059143Not Applicable
6 Weeks Right-Amygdala TIS for Depression
NCT06477276Not Applicable
Amygdala TIS for Depression
NCT06461260Not Applicable
Amygdala MRI-TIS for Depression
NCT06452849Not Applicable
Amygdala and dLPFC MRI-TIS for Depression in Adolescents
All 4 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 4